Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 109, Issue 7, Pages 1876-1885
Publisher
Springer Nature
Online
2013-09-06
DOI
10.1038/bjc.2013.534
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide
- (2015) Joanna Triscott et al. Oncotarget
- High-Throughput Chemical Screens Identify Disulfiram as an Inhibitor of Human Glioblastoma Stem Cells
- (2015) Parvinder Hothi et al. Oncotarget
- Targeting triple-negative breast cancer: optimising therapeutic outcomes
- (2012) K. Gelmon et al. ANNALS OF ONCOLOGY
- Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
- (2012) P Liu et al. BRITISH JOURNAL OF CANCER
- Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
- (2012) Josep Domingo-Domenech et al. CANCER CELL
- Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
- (2012) Xin-Sheng Deng et al. CELL CYCLE
- Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization
- (2012) Virginia Tirino et al. FASEB JOURNAL
- Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma
- (2012) Andrea Schäfer et al. NEURO-ONCOLOGY
- p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6
- (2012) Sameer Phalke et al. NUCLEIC ACIDS RESEARCH
- Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
- (2012) S. J. Conley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ErbB receptor tyrosine kinase/NF- B signaling controls mammosphere formation in human breast cancer
- (2012) K. Hinohara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
- (2012) S. M. McAuliffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
- (2012) P. Borst Open Biology
- Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
- (2011) N C Yip et al. BRITISH JOURNAL OF CANCER
- Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)
- (2011) Boris Cvek DRUG DISCOVERY TODAY
- Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer
- (2011) Yasuyo Ohi et al. HISTOPATHOLOGY
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer
- (2010) Roelof Koster et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer
- (2009) G. Frasci et al. ANNALS OF ONCOLOGY
- Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines
- (2009) Xiaoxia Guo et al. CANCER LETTERS
- Paclitaxel Directly Binds to Bcl-2 and Functionally Mimics Activity of Nur77
- (2009) C. Ferlini et al. CANCER RESEARCH
- ABC Transporters, Drug Resistance, and Cancer Stem Cells
- (2009) Michael Dean JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
- (2009) Andrea Viale et al. NATURE
- Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
- (2009) Bin-Bing S. Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Enhanced Antitumor Therapy by Inhibition of p21waf1 in Human Malignant Mesothelioma
- (2008) R. Lazzarini et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started